EA202191803A3 - MIXED COMPOSITIONS - Google Patents

MIXED COMPOSITIONS

Info

Publication number
EA202191803A3
EA202191803A3 EA202191803A EA202191803A EA202191803A3 EA 202191803 A3 EA202191803 A3 EA 202191803A3 EA 202191803 A EA202191803 A EA 202191803A EA 202191803 A EA202191803 A EA 202191803A EA 202191803 A3 EA202191803 A3 EA 202191803A3
Authority
EA
Eurasian Patent Office
Prior art keywords
composition
colloidal particles
contain
present
deformable
Prior art date
Application number
EA202191803A
Other languages
Russian (ru)
Other versions
EA202191803A2 (en
Inventor
Уильям Генри
Ричард Вольф Гаррэвэй
Original Assignee
Секвессом Текнолоджи Холдингс Лимитед
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Секвессом Текнолоджи Холдингс Лимитед filed Critical Секвессом Текнолоджи Холдингс Лимитед
Publication of EA202191803A2 publication Critical patent/EA202191803A2/en
Publication of EA202191803A3 publication Critical patent/EA202191803A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/43—Guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Dispersion Chemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Birds (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)

Abstract

Изобретение относится к составу, содержащему смеси составов (или коллоидных дисперсий), и к его местному применению. Состав содержит по меньшей мере два различных типа коллоидных дисперсий, содержащих деформируемые коллоидные частицы, где указанные деформируемые коллоидные частицы содержат неионное поверхностно-активное вещество и/или фосфолипид. Деформируемые коллоидные частицы согласно настоящему изобретению могут содержать или не содержать целевой агент (ЦА). Состав может содержать ЦА, не связанный с деформируемыми коллоидными частицами. В настоящем изобретении также предложены наборы, содержащие состав согласно настоящему изобретению, и применение состава в медицине, для ухода за кожей и в косметике.The invention relates to a formulation containing mixtures of formulations (or colloidal dispersions) and to its topical application. The composition contains at least two different types of colloidal dispersions containing deformable colloidal particles, where said deformable colloidal particles contain a non-ionic surfactant and/or a phospholipid. Deformable colloidal particles according to the present invention may or may not contain a target agent (TA). The composition may contain CA not associated with deformable colloidal particles. The present invention also provides kits containing the composition of the present invention and the use of the composition in medicine, skin care and cosmetics.

EA202191803A 2015-06-30 2016-06-30 MIXED COMPOSITIONS EA202191803A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1511469.7A GB201511469D0 (en) 2015-06-30 2015-06-30 Compositions

Publications (2)

Publication Number Publication Date
EA202191803A2 EA202191803A2 (en) 2021-10-29
EA202191803A3 true EA202191803A3 (en) 2021-12-31

Family

ID=53872451

Family Applications (1)

Application Number Title Priority Date Filing Date
EA202191803A EA202191803A3 (en) 2015-06-30 2016-06-30 MIXED COMPOSITIONS

Country Status (2)

Country Link
EA (1) EA202191803A3 (en)
GB (1) GB201511469D0 (en)

Also Published As

Publication number Publication date
GB201511469D0 (en) 2015-08-12
EA202191803A2 (en) 2021-10-29

Similar Documents

Publication Publication Date Title
MX2018009824A (en) Personal care compositions.
DOP2019000110A (en) 1,2,4–2,4,5–TRI-SUBSTITUTED TRIAZOLONES
WO2018115097A9 (en) Ophthalmic composition for treatment of dry eye disease
SV2017005461A (en) BENZAMIDS REPLACED WITH 1,3-TIAZOL-2-ILO
MX2022003572A (en) Compositions comprising a combination of an anti-pd-1 antibody and another antibody.
CL2017001115A1 (en) Stable formulation of protein in solution that contains a high concentration of an anti-vegf antibody.
BR112017022021A2 (en) application of surfactant soluble anti-dandruff agent
EA201890119A1 (en) MIXED COMPOSITIONS
BR122021018243A8 (en) LOW PH TOPICAL COMPOSITION AND METHOD TO INCREASE THE TOPICAL APPLICATION OF A COSMETICALLY ACCEPTABLE ACTIVE INGREDIENT
CL2020001762A1 (en) Crystalline forms of the 4-pyrimidinesulfamide derivative of procytentan. (divisional request 201902464)
ZA201805792B (en) Taurine and aloe synergistic anti-irritant compositions and methods
EP3686184A3 (en) Ionizable compounds and compositions and uses thereof
CO2019002889A2 (en) Combination treatments comprising the administration of imidazopyrazinones
MX2019008544A (en) Novel stable formulation for fxia antibodies.
MX2019006091A (en) Dry shampoo composition.
BR112018013170A2 (en) safe cosmetic formulation, dermatologically safe agent, and methods for reducing the amount of aluminum-based salts in perspiration and deodorant reducing formulations or for replacing said salts, for reducing antimicrobial ingredients in perspiration and deodorant reducing formulations or for replacing said ingredients and to make a cosmetic deodorant or formulation?
BR112018073862A2 (en) hair care makeup
BR112016029278A2 (en) cosmetic composition comprising a thickening polymer having hydrophobic and hydrophilic portions
BR112018009425A2 (en) new formulations
MX2018014790A (en) Combination formulation of three antiviral compounds.
WO2016113752A3 (en) Liquid formulation of cabazitaxel
EA202191803A2 (en) MIXED COMPOSITIONS
BR112017013208A2 (en) octenidine use
MX2017013265A (en) Compositions for long-lasting moisturizing cosmetic formulation comprising ucuuba butter with high concentration of myristic acid, as well as the use of said formulation for the preparation of a highly moisturizing cosmetic product and kit.
EA202191091A2 (en) MULTI-PHASE COMPOSITIONS